James Oliviero
Directeur Général chez CHECKPOINT THERAPEUTICS, INC.
Fortune : 3 M $ au 30/04/2024
Postes actifs de James Oliviero
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/10/2018 | - |
| Directeur Général | 13/10/2015 | - | |
| President | 13/10/2015 | - | |
| NUVECTIS PHARMA, INC. | Directeur/Membre du Conseil | 01/07/2021 | - |
| Independent Dir/Board Member | 01/07/2021 | - |
Historique de carrière de James Oliviero
Anciens postes connus de James Oliviero
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KERYX BIOPHARMACEUTICALS | Comptroller/Controller/Auditor | 01/05/2003 | 17/04/2015 |
| Directeur Financier/CFO | 01/04/2009 | 01/09/2015 | |
| Secrétaire Général | 01/05/2003 | 17/04/2015 | |
| Treasurer | 01/05/2003 | 01/09/2015 | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Directeur Financier/CFO | 01/08/1999 | 01/05/2003 |
Formation de James Oliviero
| Goizueta Business School-Emory | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| 2 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Health Technology |
| Nuvectis Pharma, Inc. |
- Bourse
- Insiders
- James Oliviero
- Expérience
